Response to Letter Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R 2 CHADS 2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts”
Year: 2013
Type: letter
Source: Circulation
Authors: Jonathan P. Piccini, Susanna R. Stevens, YuChiao Chang, Daniel E. Singer, Yuliya Lokhnygina, Alan S. Go, Manesh R. Patel, Kenneth W. Mahaffey, Jonathan L. Halperin, Günter Breithardt, Graeme J. Hankey, Werner Hacke, Richard C. Becker, Christopher C. Nessel, Keith A. A. Fox, Robert M. Califf
Institutions: Duke Medical Center, Duke Clinical Research Institute, Harvard University, Massachusetts General Hospital, Kaiser Permanente, Mount Sinai Health System, University of Münster, University Hospital Münster, Royal Perth Hospital, Heidelberg University, Janssen Research & Development (United States), Edinburgh Royal Infirmary, University of Edinburgh
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2205841450